At present, only a few studies investigated the heterogeneity in HER2 status in paired samples of primary and metastatic GC [19,23,24,25] and evidenced a low rate of discordance in HER2 amplification with either positive or negative conversion [19,24,25]. Here, ERBB2 is linked to gastric cancer.